In Race for Biodefense Countermeasures, Diagnostics Downplayed
Jeffrey L. Fox
Abstract
Jeffrey L. Fox
Abstract
Despite heightened surveillance and intensified efforts to develop new therapies, vaccines, and other biodefense countermeasures, the development and deployment of better diagnostic and monitoring procedures continue to be among the weak links in the overall U.S. biodefense strategy, according to several participants who spoke during the opening session of the 2005 ASM Biodefense Research Meeting, held in Washington, D.C., last February.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Despite heightened surveillance and intensified efforts to develop new therapies, vaccines, and other biodefense countermeasures, the development and deployment of better diagnostic and monitoring procedures continue to be among the weak links in the overall U.S. biodefense strategy, according to several participants who spoke during the opening session of the 2005 ASM Biodefense Research Meeting, held in Washington, D.C., last February.
Key concepts: Biodefense, Race (biology), Aeronautics, Computer science, Engineering, Biology, Microbiology, Botany